|

ASP546C Clinical Trials

1 actively recruiting trial across 1 location

Also known as: XNW27011

Pipeline

Phase 1/2: 1

Top Sponsors

  • Astellas Pharma Global Development, Inc.1

Indications

  • Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma1
  • Pancreatic Adenocarcinoma1
  • Lung Cancer1
  • Breast Cancer1
  • Cancer1

Los Angeles, California1 trial

A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

START Los Angeles

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.